SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Segment information is presented below showing revenue, significant expenses and net income/(loss) (the closest GAAP measure to Adjusted EBITDA), in the same manner that the CODM reviews the operating results in assessing performance and allocating resources.

	Three Months Ended March 31,
($ in thousands)	2025		2024
Revenue	$	39,371	$	47,620
Operating expenses:
Cost of service (exclusive of depreciation and amortization) (1)	15,950		18,042
Advertising Cost	7,152		8,366
Facility selling, general, and administrative expense	4,816		6,147
Corporate selling, general, and administrative expense (2)	9,800		1,243
Depreciation and amortization	3,242		2,805
Loss/(gain) on disposal of long-lived assets	—		5
Total operating expenses	40,960		36,608
(Loss)/income from operations	(1,589)		11,012
Interest expense, net	1,625		1,532
Pre-tax net (loss)/income	(3,214)		9,480
Income tax expense	(367)		3,451
Net loss	$	(2,847)	$	6,029
Segment assets	$	203,260	$	202,714

(1)    Cost of services includes the costs of physicians, nursing, supplies and rent directly related to the performance of procedures at the facility level.

(2)     During the first quarter of fiscal year 2024, the Company recorded a cumulative reversal of stock compensation expense of $10.4 million related to reassessing the probability of achieving the performance target on certain of the Company's performance-based stock units. See Note 6 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further discussion.